Article Data

  • Views 50
  • Dowloads 12

This is a correction to: Signa Vitae. 2024; 20(4): 99-105. https://doi.org/10.22514/sv.2024.046

Corrections

Open Access

Correction: Efficacy observation of erythropoietin on sepsis complicated with acute respiratory distress syndrome

  • Ling Jia1,†
  • Xiang Xue1,†
  • Weixiao Zhang2
  • Jianqin Cai1
  • Jinghui Yang1,*,
  • Wei Zhao1,*,

1Department of Critical Care Medicine, SIR RUN RUN hospital of Nanjing Medical University, 211100 Nanjing, Jiangsu, China

2Department of Radiology, SIR RUN RUN hospital of Nanjing Medical University, 211100 Nanjing, Jiangsu, China

DOI: 10.22514/sv.2026.040 Vol.22,Issue 3,August 2026 pp.160-161

Published: 08 August 2026

*Corresponding Author(s): Jinghui Yang E-mail: Yangjinghui911@163.com
*Corresponding Author(s): Wei Zhao E-mail: zhaowei8051@163.com

† These authors contributed equally.

Cite and Share

Jia L, Xue X, Zhang W, Cai J, Yang J, Zhao W. Correction: Efficacy observation of erythropoietin on sepsis complicated with acute respiratory distress syndrome. Signa Vitae. 2026; 22(3): 160-161. doi: 10.22514/sv.2026.040

References

[1] Jia L, Xue X, Zhang WX, Cai JQ, Yang JH, Zhao W. Efficacy observation of erythropoietin on sepsis complicated with acute respiratory distress syndrome. Signa Vitae. 2024; 20: 99–105.

Submission Turnaround Time

Top